fda bpc-157 compounding safety concerns Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC-157 Legit — Audit of
Description
However, this isnt strictly true for many of the peptides, but its the way he characterized it

Published analyses report contamination prevalence from 10% to 35% in some supplement categories

In preclinical work it is described as an "exercise-mimetic" supporting insulin sensitivity, glucose handling and fat oxidation

A named supplier is part of the quality signal
Refrigeration: helpful, but not a substitute for clean technique The standard advice is correct: refrigerate reconstituted peptides

If you have any questions or concerns about your health, please speak to your doctor.